MINIMEDTM 630G INSULIN PUMP SYSTEM
The MiniMed™ 630G insulin pump features innovative technology to more closely mimic the way a healthy pancreas delivers basal insulin to the body in order to help you to achieve better control.
Explore the MiniMedTM 630G
EXCLUSIVE CONTOUR® NEXT LINK 2.4 wireless blood glucose monitoring system
When combined with the CONTOUR® NEXT LINK 2.4 meter,1 results are wirelessly transmitted to help ensure insulin dosing, and remote bolusing in an easy-to-use sleek design.
MINIMED™ 630G PUMP
User-friendly, waterproof† design
- Waterproof protection
- Colour screen with auto-brightness
- Easy-to-use menu and buttons
- Airplane mode for travel
- Polished black exterior finish; easily customisable with a wide variety of personalised skins
Remote insulin dosing
- Highly accurate wireless CONTOUR® NEXT LINK 2.4 meter (a MiniMed™ system exclusive)
- Quick, easy delivery of a bolus
Fewer injections
- Small device worn on your body that continuously delivers insulin
- Tubing changes needed only every two or three days
Adjustable settings
- Multiple insulin delivery settings
TAKE THE NEXT STEP
Fill out the form to be contacted by a MiniMed 630G consultant from Medtronic.
*
The Bolus Wizard™ calculator does not account for manual injections and could prompt you to deliver more insulin than needed. Too much insulin may cause hypoglycaemia. Consult with your healthcare professional for how long you need to wait after a manual injection before you can rely on the active insulin calculation of your Bolus Wizard™ calculator.
†
At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours.
‡
Individual results may vary.
1
Bailey T, et al. Accuracy, Precision, and User Performance Evaluation of the CONTOUR® NEXT LINK 2.4 Blood Glucose Monitoring System. Poster presented at the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); 2014 February 5–8, Vienna, Austria.
2
Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia. 2012;55:3155–3162.
3
Doyle EA, Weinzimer SA, Steffen AT, Ahern JAH, Vincent M, Tamborlane WV. A randomized prospective trial comparing the efficacy of insulin pump therapy with multiple daily injections using insulin glargine. Diabetes Care. 2004;27(7):1554–1558.
4
Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care. 1996;19:324–327.
5
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.
